Advanced Enzyme Technologies (NSE:ADVENZYMES) Debt-to-Equity : N/A (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Advanced Enzyme Technologies Debt-to-Equity?

Advanced Enzyme Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Advanced Enzyme Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Advanced Enzyme Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Advanced Enzyme Technologies's Debt-to-Equity or its related term are showing as below:

NSE:ADVENZYMES' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.04 Max: 0.54
Current: 0.04

During the past 13 years, the highest Debt-to-Equity Ratio of Advanced Enzyme Technologies was 0.54. The lowest was 0.02. And the median was 0.04.

NSE:ADVENZYMES's Debt-to-Equity is ranked better than
89.34% of 1389 companies
in the Chemicals industry
Industry Median: 0.37 vs NSE:ADVENZYMES: 0.04

Advanced Enzyme Technologies Debt-to-Equity Historical Data

The historical data trend for Advanced Enzyme Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Enzyme Technologies Debt-to-Equity Chart

Advanced Enzyme Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.03

0.04

Advanced Enzyme Technologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.04	N/A	0.04	N/A

Competitive Comparison of Advanced Enzyme Technologies's Debt-to-Equity

For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Enzyme Technologies's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Advanced Enzyme Technologies's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Advanced Enzyme Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Advanced Enzyme Technologies's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(244.92	+	228.16)	/	13241.28
	=	0.04

Advanced Enzyme Technologies's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Advanced Enzyme Technologies (NSE:ADVENZYMES) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Advanced Enzyme Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Advanced Enzyme Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Enzyme Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Advanced Enzyme Technologies Ltd (NSE:ADVENZYMES) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

540025:India

Address

Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604

Website

https://www.advancedenzymes.com

Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The Company operates only in one business segment viz. manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.

Advanced Enzyme Technologies Headlines

No Headlines